ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

TNYA Tenaya Therapeutics Inc

4.68
0.06 (1.30%)
May 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 91,741
Bid Price 4.35
Ask Price 4.99
News -
Day High 4.96

Low
1.66

52 Week Range

High
8.0914

Day Low 4.59
Share Name Share Symbol Market Stock Type
Tenaya Therapeutics Inc TNYA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.06 1.30% 4.68 19:00:00
Open Price Low Price High Price Close Price Previous Close
4.72 4.59 4.96 4.68 4.62
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,278 91,741 US$ 4.74 US$ 434,398 - 1.66 - 8.0914
Last Trade Type Quantity Price Currency
16:40:56 1 US$ 4.68 USD

Tenaya Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
319.44M 68.11M - 0 -124.08M -1.82 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Tenaya Therapeutics News

Date Time Source News Article
5/02/202416:00GlobeNewswire Inc.Tenaya Therapeutics to Highlight Growing Capabilities in..
3/18/202415:05GlobeNewswire Inc.Tenaya Therapeutics Reports Fourth Quarter and Full Year..
3/18/202407:30GlobeNewswire Inc.Tenaya Therapeutics Announces Publication of TN-401 Gene..
2/27/202418:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/27/202415:30GlobeNewswire Inc.Tenaya Therapeutics to Participate in Upcoming March..
2/26/202407:30GlobeNewswire Inc.Tenaya Therapeutics Announces Publication of Preclinical..
2/16/202419:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/16/202419:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
2/08/202416:25Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
2/08/202407:15Edgar (US Regulatory)Form 8-K - Current report
2/08/202407:00GlobeNewswire Inc.Tenaya Therapeutics Announces Pricing of Underwritten..
1/31/202415:11Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TNYA Message Board. Create One! See More Posts on TNYA Message Board See More Message Board Posts

Historical TNYA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.224.964.224.56148,2980.4610.90%
1 Month4.544.963.974.46256,9570.143.08%
3 Months5.297.013.975.28504,232-0.61-11.53%
6 Months2.237.011.704.28476,5572.45109.87%
1 Year5.298.09141.664.69465,141-0.61-11.53%
3 Years19.5032.001.646.26317,817-14.82-76.00%
5 Years19.5032.001.646.26317,817-14.82-76.00%

Tenaya Therapeutics Description

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.

Your Recent History

Delayed Upgrade Clock